Login / Signup
Lilin She
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 3
Top Topics
Placebo Controlled
Clinical Trial
Phase Ii
Open Label
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Tira Jing Ying Tan
,
Sarah L Sammons
,
Young-Hyuck Im
,
Lilin She
,
Kelly Mundy
,
Robert Bigelow
,
Tiffany A Traina
,
Carey K Anders
,
Joe Poh Sheng Yeong
,
Ezequiel Renzulli
,
Sung-Bae Kim
,
Rebecca A Dent
Phase II DORA Study of Olaparib with or without Durvalumab as a Chemotherapy-Free Maintenance Strategy in Platinum-Pretreated Advanced Triple-Negative Breast Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (7) (2024)
Tira Jing Ying Tan
,
Sarah L Sammons
,
Young-Hyuck Im
,
Lilin She
,
Kelly Mundy
,
Robert Bigelow
,
Tiffany A Traina
,
Carey K Anders
,
Joe Poh Sheng Yeong
,
Ezequiel Renzulli
,
Sung-Bae Kim
,
Rebecca A Dent
Phase II DORA Study of Olaparib with or without Durvalumab as a Chemotherapy-Free Maintenance Strategy in Platinum-Pretreated Advanced Triple-Negative Breast Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2024)
Tira Jing Ying Tan
,
Sarah L Sammons
,
Young-Hyuck Im
,
Lilin She
,
Kelly Mundy
,
Robert Bigelow
,
Tiffany A Traina
,
Carey K Anders
,
Joe Poh Sheng Yeong
,
Ezequiel Renzulli
,
Sung-Bae Kim
,
Rebecca A Dent
Phase II DORA Study of Olaparib with or without Durvalumab as a Chemotherapy-Free Maintenance Strategy in Platinum-Pretreated Advanced Triple-Negative Breast Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (7) (2024)